24/7
Buzz
Startups
VC
AI
Innovation
Opinions
Events
Promising Startups 2024
BiblioTech
Boarding Pass
Corporate
Appointments
CTalk
Tech Gateways
2025 VC survey
@Finance
Ctech Testimonials
Shopping
Projects
Spotlight
About
Newsletter
Contact us
Facebook
Twitter
ACCESSIBILITY
by
Homepage
Mapi Pharma
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
Innovation
OPINIONS
EVENTS
SHOPPING
ABOUT
teram of use
Privacy Policy
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
18:25
Tomorrow.io raises $175 million at over $1 billion valuation to build AI-driven weather satellite network
15:30
Cyber startup Orion raises $32 million Series A backed by IBM for AI-driven data-leak prevention
15:08
Full list of Israeli startup M&As in 2026
15:05
Medtronic to acquire Israeli AI cardiology firm CathWorks for $585 million, deal could reach $1 billion
More stories
Buzz
Most popular
Daily
Weekly
1
Chinese fund: “The Chinese government has imposed a ban on any new investment in Israel”
2
Why Apple paid billions for a company with no revenue
3
Israeli startups raise over $1 billion in January, marking best opening month since 2022
4
Valued at $800 million after less than two years, Vega eyes the path blazed by Wiz
5
“SaaS is dying as a business category”
More news
Mapi Pharma
2 stories about Mapi Pharma
Copaxone-Competitor Developer Mapi Pharma Gets Funding for Jerusalem Plant
19.03.19
|
Lilach Baumer
The clinical-stage company develops more efficient versions of existing successful drugs, including a long-acting version of Teva's multiple sclerosis cash cow
Drug Developer Mapi Pharma Raises $10 Million from China's Jingxin Pharm
06.11.18
|
Lilach Baumer
The Xinchang, China-headquartered generic drugmaker is an existing investor, having made an initial $10 million investment in Mapi in 2016